首页 | 官方网站   微博 | 高级检索  
     

安体舒通联合强的松治疗特发性肺纤维化
引用本文:涂明利,张红梅,刘培,刘先军,张景鸿,盛春风. 安体舒通联合强的松治疗特发性肺纤维化[J]. 郧阳医学院学报, 2008, 27(2): 140-142
作者姓名:涂明利  张红梅  刘培  刘先军  张景鸿  盛春风
作者单位:郧阳医学院附属太和医院呼吸内科,湖北十堰442000
摘    要:目的:探讨安体舒通联合强的松治疗特发性肺纤维化(Id iopath ic pu lmonary fibrosis,IPF)的临床疗效和安全性。方法:将IPF患者22例随机分为两组:治疗组12例,安体舒通联合强的松治疗;对照组10例,单用强的松治疗。观察咳嗽和呼吸困难等症状、胸部HRCT和肺功能、血电解质和血压。结果:治疗1月两组均有明显疗效,反应良好者治疗组达8例(75%),对照组8例(80%);疗程12月,治疗组反应良好者为6例(50%),对照组3例(30%),P<0.05。对照组有1~2例(10%~20%)患者发生低血钾和高血压,治疗组则没有发生。结论:与单用强的松相比,安体舒通联合强的松能提高IPF的疗效,比单用强的松副反应减少。

关 键 词:肺纤维化  安体舒通  强的松
文章编号:1006-9674(2008)02-0140-03
修稿时间:2008-01-06

Effects of Spironolactone Combined with Prednisone on Patients with Idiopathic Pulmonary Fibrosis
TU Ming-li,ZHANG Hong-mei,LIU Pei,LIU Xian-jun,ZHANG Jing-hong,SHENG Chun-feng. Effects of Spironolactone Combined with Prednisone on Patients with Idiopathic Pulmonary Fibrosis[J]. Journal of Yunyang Medical College, 2008, 27(2): 140-142
Authors:TU Ming-li  ZHANG Hong-mei  LIU Pei  LIU Xian-jun  ZHANG Jing-hong  SHENG Chun-feng
Affiliation:Department of Respiratory;Taihe Hospital;Yunyang Medical College;Shiyan;Hubei 442000;China
Abstract:Objective To observe the therapeutic effects of spironolactone combined with prednisone on patients with idiopathic pulmonary fibrosis(IPF).Methods Twenty-two patients were randomly divided into 2 groups:the spironolactone combined with prednisone group(n=12),prednisone group(n=10).All patients were followed up for 12 months.The changes of the dyspnea,cough,blood pressure,and the index changes of high resolution computerized tomography of chest,lung function test,arterial blood gas detection,the level of po...
Keywords:Idiopathic pulmonary fibrosis  Spironolactone  Prednisone  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号